Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage
Abstract
Severe preeclampsia frequently requires the concurrent administration of magnesium sulfate, intravenous nicardipine, and volatile anesthetics during the peri-delivery period, exposing the myometrium to convergent inhibition of calcium-dependent contraction. We conducted a narrative review guided by the Scale for the Assessment of Narrative Review Articles framework. We searched PubMed/MEDLINE and screened reference lists through March 2026, prioritizing mechanistic studies, human myometrial experiments, clinical cohorts, randomized trials, meta-analyses, and contemporary obstetric anesthesia guidance. The evidence indicates that convergence occurs at multiple levels of the excitation-contraction coupling machinery, including L-type calcium channel influx, inositol 1,4,5-trisphosphate-mediated intracellular calcium release, oxytocin receptor signaling, intercellular coupling through connexin-43 gap junctions, and calcium sensitization via the Ras homolog family member A (RhoA)/Rho-kinase pathway. Magnesium sulfate acts as a broad calcium antagonist, nicardipine blocks L-type calcium channels, and volatile anesthetics depress spontaneous and oxytocin-induced force generation. Clinical evidence is more heterogeneous: magnesium sulfate shows mixed hemorrhagic associations, direct postpartum hemorrhage data for nicardipine remain sparse, and general anesthesia is associated with greater hemorrhagic risk than neuraxial techniques. This “tocolytic triad” is therefore best viewed as a mechanistically grounded risk model rather than a validated clinical syndrome. We propose a graded exposure-burden care bundle, anchored in quantified blood loss assessment, to align hemorrhage preparedness with cumulative pharmacologic inhibition of postpartum uterine contraction.
Related
- Pharmacokinetics of Local Anesthetics in Fascial Plane Blocks: Clinical Implications and Safety Considerations-A Narrative Review.
- Lipoprotein(a) and Plaque Vulnerability: Mechanistic Insights, Imaging Evidence, and Clinical Implications
- Obesity and Oral Health: Clinical Associations, Mechanistic Evidence, and Implications for Dental Care—A Narrative Review
- Environmental phthalate and chronic kidney disease: Epidemiology, mechanistic pathways, and clinical implications
- GClnc1 as an emerging oncogenic regulator with mechanistic insights and clinical implications in human cancers
BibTeX
@article{bouya2026magnesium,
title = {{Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage}},
author = {Mohammed Said Bouya and Zakariya Hamdani and Najib Bouhabba and Yang Pan},
journal = {Maternal-fetal medicine (Wolters Kluwer Health, Inc.)},
year = {2026},
month = jul,
doi = {10.1097/fm9.0000000000000372},
url = {https://europepmc.org/article/PMC/PMC13706455},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage
AU - Mohammed Said Bouya
AU - Zakariya Hamdani
AU - Najib Bouhabba
AU - Yang Pan
PY - 2026
DA - 2026/07/29
JO - Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
DO - 10.1097/fm9.0000000000000372
UR - https://europepmc.org/article/PMC/PMC13706455
AB - Severe preeclampsia frequently requires the concurrent administration of magnesium sulfate, intravenous nicardipine, and volatile anesthetics during the peri-delivery period, exposing the myometrium to convergent inhibition of calcium-dependent contraction. We conducted a narrative review guided by the Scale for the Assessment of Narrative Review Articles framework. We searched PubMed/MEDLINE and screened reference lists through March 2026, prioritizing mechanistic studies, human myometrial experiments, clinical cohorts, randomized trials, meta-analyses, and contemporary obstetric anesthesia guidance. The evidence indicates that convergence occurs at multiple levels of the excitation-contraction coupling machinery, including L-type calcium channel influx, inositol 1,4,5-trisphosphate-mediated intracellular calcium release, oxytocin receptor signaling, intercellular coupling through connexin-43 gap junctions, and calcium sensitization via the Ras homolog family member A (RhoA)/Rho-kinase pathway. Magnesium sulfate acts as a broad calcium antagonist, nicardipine blocks L-type calcium channels, and volatile anesthetics depress spontaneous and oxytocin-induced force generation. Clinical evidence is more heterogeneous: magnesium sulfate shows mixed hemorrhagic associations, direct postpartum hemorrhage data for nicardipine remain sparse, and general anesthesia is associated with greater hemorrhagic risk than neuraxial techniques. This “tocolytic triad” is therefore best viewed as a mechanistically grounded risk model rather than a validated clinical syndrome. We propose a graded exposure-burden care bundle, anchored in quantified blood loss assessment, to align hemorrhage preparedness with cumulative pharmacologic inhibition of postpartum uterine contraction.
SN - 2096-6954
SN - 2641-5895
ER -